Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
eszopiclone (lunesta) (1 trial)
oxymorphone (opana) (1 trial)
lubiprostone (amitiza) (1 trial)
loxapine (loxitane) (1 trial)
oxytocin (syntocinon) (1 trial)
water (1 trial)
Chronic Pain (Phase 4)
Gastrointestinal Diseases (Phase 3)
Intestinal Diseases (Phase 3)
Migraine Disorders (Phase 4)
Sleep Initiation and Maintenance Disorders (Phase 4)
Trials (5 total)
Trial APIs (6 total)